Why You Should Retain Merit Medical (MMSI) Stock for Now
https://www.zacks.com/stock/news/2196236/why-you-should-retain-merit-medical-mmsi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196236
Dec 11, 2023 - Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
0
AMN Healthcare's (AMN) New Tie-Up to Boost Patient Outcome
https://www.zacks.com/stock/news/2195558/amn-healthcare-s-amn-new-tie-up-to-boost-patient-outcome?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2195558
Dec 08, 2023 - AMN Healthcare's (AMN) collaboration is likely to bolster its portfolio of products and simplify the language procurement process for customers.
0
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
https://www.zacks.com/stock/news/2194846/here-s-why-you-should-retain-opko-health-opk-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2194846
Dec 07, 2023 - OPKO Health's (OPK) potential in Rayaldee raises optimism about the stock.
0
3 Reasons to Retain AMN Healthcare (AMN) Stock in Your Portfolio
https://www.zacks.com/stock/news/2194242/3-reasons-to-retain-amn-healthcare-amn-stock-in-your-portfolio?cid=CS-ZC-FT-analyst_blog|rank_focused-2194242
Dec 06, 2023 - Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
0
West Pharmaceutical's (WST) New Launch to Expand Portfolio
https://www.zacks.com/stock/news/2193729/west-pharmaceutical-s-wst-new-launch-to-expand-portfolio?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193729
Dec 05, 2023 - West Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care.
0
Community Health (CYH) Sells Three Florida Facilities for $294M
https://www.zacks.com/stock/news/2193200/community-health-cyh-sells-three-florida-facilities-for-294m?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193200
Dec 04, 2023 - Community Health (CYH) divests three hospitals in Florida to Tampa General Hospital, substantiating its endeavor to intensify its focus on high-growth business areas.
0
Here's Why You Should Invest in Haemonetics (HAE) Right Now
https://www.zacks.com/stock/news/2193129/here-s-why-you-should-invest-in-haemonetics-hae-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2193129
Dec 04, 2023 - Investors are optimistic about Haemonetics (HAE) on consistent growth performance and raised guidance.
0
Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2192765/reasons-to-retain-stryker-syk-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2192765
Dec 04, 2023 - Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
0
ITGR vs. EW: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2192337/itgr-vs-ew-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2192337
Dec 01, 2023 - ITGR vs. EW: Which Stock Is the Better Value Option?
0